Binimetinib

Overview

Binimetinib is an oral, highly selective MEK1/2 inhibitor used in combination with encorafenib for BRAF V600E/K-mutated unresectable or metastatic melanoma and non-small cell lung cancer.

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Binimetinib and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-455720
• CAS No.: 606143-89-9
• Molecular Formula: C17H15BrF2N4O3
• Molecular Weight: 441.23
• Purity: >98%
• Storage: Store at -20 °C
• Solubility: Soluble in DMSO

Source

Original product source